Skip to main content

Table 4 Distribution of C1858T, A49G, and C(−318)T genotypes in the study group and control group

From: Association between genetic mutations and the development of autoimmune thyroiditis in patients with chronic hepatitis C treated with interferon alpha

SNP

Genotypes

Study group (n=101)

Control group (n=200)

C1858T

CC

74 (73.2%)

147 (73.5%)

 

CT

25 (24.8%)

50 (25.0%)

 

TT

2 (2.0%)

3 (1.5%)

 

p=0.95347

A49G

AA

43 (42.6%)

81 (40.5%)

 

AG

58 (57.4%)

105 (52.5%)

 

GG

0 (0.0%)

14 (7.0%)

 

p=0.02423

C(−318)T

CC

79 (78.2%)

151 (75.5%)

 

CT

20 (19.8%)

48 (24.0%)

 

TT

2 (1.98%)

1 (0.5%)

 

p=0.35636